In vitro functional defects of bone marrow-derived CD34+ progenitors from newly diagnosed mature B-cell malignancies with bone marrow tumor involvement. - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Experimental Hematology Année : 2005

In vitro functional defects of bone marrow-derived CD34+ progenitors from newly diagnosed mature B-cell malignancies with bone marrow tumor involvement.

Patricia Amé-Thomas
  • Fonction : Auteur
Frédéric Deschaseaux
  • Fonction : Auteur
Claude-Eric Bulabois
  • Fonction : Auteur
Thierry Lamy
  • Fonction : Auteur
Patrick Hervé
  • Fonction : Auteur
Jean-Yves Cahn
  • Fonction : Auteur

Résumé

OBJECTIVE: We hypothesized that the presence of tumor cells in bone marrow (BM) could alter hematopoietic progenitor cell functions. Therefore, we evaluated phenotypic and in vitro functional properties of BM-derived CD34+ progenitors issued from untreated and newly diagnosed patients presenting a mature B-lymphoproliferative disorder (LPD) involving the BM (Inv+). PATIENTS AND METHODS: In vitro proliferation and differentiation capacities of primitive and committed progenitors were evaluated by cobblestone area-forming cell (CAFC) and colony-forming cell (CFC) assays, and ex vivo cell expansion. Migratory capacities of CD34+ cells were explored by chemotaxis assays using a CXCL12alpha gradient. RESULTS: Our results showed that CD34+ cells from Inv+ patients overexpressed CD117 and had a significant decrease of week-3 and -6 CAFC, and CFC frequencies, compared to cells obtained from healthy volunteers and LPD patients without BM involvement (Inv-). In addition, progenitors from Inv+ patients maintained a significantly decreased CFC capacity after ex vivo cell expansion, compared to healthy volunteers. However, the former cells held their migratory capacity in response to CXCL12alpha. CONCLUSION: Functional defects of primitive and committed CD34+ progenitors detected among LPD patients with BM tumor involvement suggest either that tumor cells may induced bystander effects on progenitors or that "unusual" CD34+ cells may exist in the BM that could belong to the proliferating tumor tissue.

Dates et versions

hal-00453118 , version 1 (03-02-2010)

Identifiants

Citer

Patricia Amé-Thomas, Frédéric Deschaseaux, Frédéric Mauny, Claude-Eric Bulabois, Thierry Lamy, et al.. In vitro functional defects of bone marrow-derived CD34+ progenitors from newly diagnosed mature B-cell malignancies with bone marrow tumor involvement.. Experimental Hematology, 2005, 33 (3), pp.318-28. ⟨10.1016/j.exphem.2004.11.016⟩. ⟨hal-00453118⟩
85 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More